Showing 1 - 5 of 5
More testing, treatment needed
Oped, Poonam Khetrapal, Published on 03/08/2023
» To mark World Hepatitis Day, the World Health Organization (WHO) is urging policymakers, health care providers and political and civil society leaders in the Southeast Asia region and globally to accelerate hepatitis testing and treatment, recognising that everyone, everywhere has just "one life" and "one liver" -- the theme of this year's event.
Time to boost region's oral health
Oped, Poonam Khetrapal, Published on 22/03/2023
» On World Oral Health Day which fell on Monday, WHO urge Southeast Asian countries to accelerate implementation of the region's new Action Plan for Oral Health 2022–2030, which aims to ensure that everyone, everywhere in Southeast Asia can enjoy the highest attainable state of oral health, with a focus on achieving universal coverage for oral health by 2030.
Fighting cancer in Southeast Asia
Oped, Poonam Khetrapal, Published on 07/02/2023
» On World Cancer Day, which is concurrent on Feb 4 annually, the WHO is calling for intensified action across the Southeast Asian region to strengthen health systems to prevent and detect cancers early, to provide prompt treatment referral, to enhance access to palliative care, and to close the gap in access to quality cancer services -- the theme of this year's commemoration.
Plan to build back better in SE Asia
News, Poonam Khetrapal, Published on 14/09/2021
» The world is at a crossroads. Almost two years since SARS-CoV-2 was detected, some countries globally are returning normal, or something very close. Many more countries -- including in the WHO South-East Asia Region -- continue to aggressively respond, battling new and more transmissible variants. Social and economic disruptions continue.
Don't forget about viral hepatitis
Oped, Poonam Khetrapal, Published on 29/07/2021
» The World Health Organization (WHO) Southeast Asia region is intensifying action to eliminate viral hepatitis as a public health threat by 2030. Globally, an estimated 296 million people live with chronic hepatitis B and around 58 million live with chronic hepatitis C. In 2019, viral hepatitis caused nearly 1.1 million deaths globally, despite the existence of safe and effective vaccines that can prevent hepatitis B and antiviral drugs that can manage chronic hepatitis B and cure most cases of hepatitis C. An estimated 60 million people in the region live with chronic hepatitis B and around 10.5 million live with chronic hepatitis C. In 2019, around 180,000 people in the region died of hepatitis B and about 38,000 died of hepatitis C -- both completely manageable.